Table of Contents Author Guidelines Submit a Manuscript
International Journal of Analytical Chemistry
Volume 2015, Article ID 820517, 8 pages
http://dx.doi.org/10.1155/2015/820517
Research Article

Stability-Indicating HPLC Determination of Trandolapril in Bulk Drug and Pharmaceutical Dosage Forms

1Faculty of Pharmacy and Medical Sciences, Al-Ahliyya Amman University, P.O. Box 263, Amman 19328, Jordan
2Arab Company for Drug Industries and Medical Appliances (ACDIMA), P.O. Box 925161, Amman 11190, Jordan
3Faculty of Pharmacy, Middle East University, Airport Road, Amman 11831, Jordan

Received 30 September 2014; Revised 2 January 2015; Accepted 5 January 2015

Academic Editor: Philip M. Williams

Copyright © 2015 Leena A. Al-Hawash et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. D. R. P. Guay, “Trandolapril: a newer angiotensin-converting enzyme inhibitor,” Clinical Therapeutics, vol. 25, no. 3, pp. 713–775, 2003. View at Publisher · View at Google Scholar · View at Scopus
  2. L. Køber, C. Torp-Pedersen, J. E. Carlsen et al., “A clinical trial of the angiotensin-converting-enzyme inhibitor trandolapril in patients with left ventricular dysfunction after myocardial infarction,” The New England Journal of Medicine, vol. 333, no. 25, pp. 1670–1676, 1995. View at Publisher · View at Google Scholar · View at Scopus
  3. R.-I. Stefan, J. F. van Staden, and H. Y. Aboul-Enein, “Detection of S-enantiomers of cilazapril, pentopril and trandolapril using a potentiometric, enantioselective membrane electrode,” Electroanalysis, vol. 11, no. 3, pp. 192–194, 1999. View at Google Scholar · View at Scopus
  4. R.-I. Stefan, J. F. van Staden, and H. Y. Aboul-Enein, “Analysis of chiral drugs with enantioselective biosensors. An overview,” Electroanalysis, vol. 11, no. 16, pp. 1233–1235, 1999. View at Google Scholar · View at Scopus
  5. C. Pistos, M. Koutsopoulou, and I. Panderi, “Liquid chromatographic tandem mass spectrometric determination of trandolapril in human plasma,” Analytica Chimica Acta, vol. 540, no. 2, pp. 375–382, 2005. View at Publisher · View at Google Scholar · View at Scopus
  6. A. Gumieniczek and H. Hopkala, “High-performance liquid chromatographic assay of trandolapril in capsules,” Acta Poloniae Pharmaceutica—Drug Research, vol. 57, no. 4, pp. 253–255, 2000. View at Google Scholar · View at Scopus
  7. A. Gumieniczek and H. Hopkala, “Development and validation of a liquid chromatographic method for the determination of trandolapril and verapamil in capsules,” Journal of Liquid Chromatography and Related Technologies, vol. 24, no. 3, pp. 393–400, 2001. View at Publisher · View at Google Scholar · View at Scopus
  8. C. Rambabu, G. Ramu, A. Biksham Babu, and S. Venkata Rao, “Optimized and validated reverse phase HPLC method for the determination of trandolapril in bulk and formulations,” Rasayan Journal of Chemistry, vol. 3, no. 4, pp. 777–782, 2010. View at Google Scholar · View at Scopus
  9. I. Cendrowska, K. Bańkowski, and J. Iskra-Jopa, “A study on the stereochemical purity of trandolapril and octahydro-1H-indole-2-carboxylic acid by HPLC method,” Acta Poloniae Pharmaceutica—Drug Research, vol. 60, no. 2, pp. 141–144, 2003. View at Google Scholar · View at Scopus
  10. E. R. Dawud and A. K. Shakya, “HPLC-PDA analysis of ACE-inhibitors, hydrochlorothiazide and indapamide utilizing design of experiments,” Arabian Journal of Chemistry, 2014. View at Publisher · View at Google Scholar
  11. Y. B. Manju Latha and D. Gowri Sankar, “Stability indicating RP-HPLC method for determination of Trandolapril (TP) in pure and pharmaceutical formulation,” International Journal of Drug Development and Research, vol. 5, no. 4, pp. 98–105, 2013. View at Google Scholar · View at Scopus
  12. M. Dendeni, N. Cimetiere, A. Amrane, and N. B. Hamida, “Impurity profiling of trandolapril under stress testing: structure elucidation of by-products and development of degradation pathway,” International Journal of Pharmaceutics, vol. 438, no. 1-2, pp. 61–70, 2012. View at Publisher · View at Google Scholar · View at Scopus
  13. K. Sahu, C. Karthikeyan, N. S. H. N. Moorthy, and P. Trivedi, “A validated UPLC method used for the determination of trandolapril and its degradation products as per ICH guidelines,” Current Pharmaceutical Analysis, vol. 7, no. 3, pp. 182–188, 2011. View at Publisher · View at Google Scholar · View at Scopus
  14. D. Kowalczuk, “Simultaneous high-performance thin-layer chromatography densitometric assay of trandolapril and verapamil in the combination preparation,” Journal of AOAC International, vol. 88, no. 5, pp. 1525–1529, 2005. View at Google Scholar · View at Scopus
  15. R. J. R. Vikas, L. Sathiyanarayanan, and S. S. Yadav, “Stability indicating HPTLC method for trandolapril estimation in the bulk drug and tablet dosage form,” Indian Journal of Pharmaceutical Education and Research, vol. 44, no. 4, pp. 341–344, 2010. View at Google Scholar · View at Scopus
  16. S. K. Dubey, S. Kumar, R. J. Mudakavi, S. Deshpande, and A. K. Jain, “Development and validation of UV-spectrophotometric method for determination of Enalapril maleate,” International Journal of Advances in Pharmaceutical Sciences, vol. 1, no. 4, pp. 375–380, 2010. View at Publisher · View at Google Scholar · View at Scopus
  17. M.-E. Capella-Peiró, M. Font-Rubert, L. Àlvarez-Rodríguez, J. Esteve-Romero, A. Durgbanshi, and D. Bose, “Optimization using a factorial design for the separation of trandolapril and verapamil by capillary electrophoresis,” Journal of Liquid Chromatography and Related Technologies, vol. 30, no. 20, pp. 2975–2988, 2007. View at Publisher · View at Google Scholar · View at Scopus
  18. British Pharmacopoeia, 2008, http://www.sinoapi.com/Pharmacopoeia/pharmacopoeia-bp2009.asp?cas=87679-37-6.
  19. IFPMA, “Stability ICH testing of new drug substances and products Q1A (R2),” in Proceedings of the International Conference on Harmonization, IFPMA, Geneva, Switzerland, 2003.
  20. IFPMA, “ICH validation of analytical procedures: text and methodology Q2 (R1),” in Proceedings of the International Conference on Harmonization, IFPMA, Geneva, Switzerland, 2005.
  21. United States Pharmacopoeia, “United states pharmacopeial convention,” Tech. Rep. USP 27, NF 22, United States Pharmacopoeia, Rockville, Md, USA, 2004. View at Google Scholar